Heart Attack Diagnostics Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Heart Attack Diagnostics Market in 2025 is evaluated at USD 14.97 billion. The global market size was estimated at over USD 14.06 billion in 2024 and is anticipated to grow at a CAGR of 8.1%, with projections indicating it will exceed USD 38.7 billion by 2037. North America is expected to dominate the industry, impelled by rising incidence of cardiac diseases and increased healthcare spending.
The growth of the market can primarily be ascribed to the rising number of people suffering from heart attacks globally, owing to unhealthy lifestyles, consumption of fatty food items, and illnesses. According to the Centers for Disease Control and Prevention in the United States, about 805,000 people have a heart attack each year. There are 605,000 first-time heart attacks among these. In 200,000 cases, people who have already suffered a heart attack are affected.
Global heart attack diagnostics market trends such as, the rising disposable income of the population along with rising healthcare expenditure and rapid awareness about health and fitness is expected to boost up the global market in the forecast period. Centers for Medicare & Medicaid Services stated that U.S. health care spending grew 9.7 percent in 2020, reaching USD 4.1 trillion or USD 12,530 per person. Moreover, pre heart attack symptoms should be known by everyone to avoid these unpleasant instances since even a mild heart attack can cause severe medical conditions. Mild heart attack symptoms include tightness & squeezing in the chest, fatigue, heartburn, nausea, dizziness, and others.
Heart Attack Diagnostics Market: Growth Drivers and Challenges
Growth Drivers
- Rise in Geriatric Population Worldwide - Globally, there were 747,238,580 people over 60 years old at the end of 2021 according to a recent World Bank report. Future projections indicate an increase in the number. Cardiovascular disease is more prevalent among the elderly and the aging population. Adults with cardiovascular disease are at an increased risk of CVD owing to their age, which is increased by contributing factors such as fragility, overweight, and diabetes. Moreover, aging populations are more likely to suffer from heart attacks because they are more vulnerable to heart diseases.
- Higher Level of Cholesterol Among People- As per the data by the Centers for Disease Control and Prevention, the total cholesterol level of nearly 94 million U.S. adults aged 20 or older exceeds 200 mg/dL. A total of 28 million Americans has a cholesterol level above 240 milligrams per deciliter.
- Increasing Consumption of Alcohol - The consumption of alcohol is directly related to a higher risk of stroke and heart failure. According to a survey of adults ages 18 and older, 84% reported drinking alcohol at some point in their lives across the globe.
- High Rate of Tobacco Smoking- For instance, the number of adults smoking cigarettes in the United States is estimated at 30.8 million. There are more than 16 million Americans who suffer from smoking-related diseases.
- Prevalence of Unhealthy Lifestyles Among People - It was observed that, there are approximately 677,000 deaths each year in the United States as a result of unhealthy lifestyles, such as cardiovascular disease, cancer, and diabetes, which are linked to nutrition and obesity.
Challenges
- Higher Price Associated with Diagnostic Products – Even if heart attack cases are increasing at an alarming rate, heart attack diagnostic procedure cost a fortune owing to high price of diagnostic products. As a result, the population with middle income is expected to slower the adoption rate of heart diagnostic in the forecast period.
- Shortage of Skilled Medical Professionals
- Inadequate Medicare Reimbursement Policies
Heart Attack Diagnostics Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.1% |
|
Base Year Market Size (2024) |
USD 14.06 billion |
|
Forecast Year Market Size (2037) |
USD 38.7 billion |
|
Regional Scope |
|
Heart Attack Diagnostics Segmentation
End-user (Hospitals & Clinics, Diagnostic Center, Ambulatory & Surgical Centers)
The global heart attack diagnostics market is segmented and analyzed for demand and supply by end-user into hospitals & clinics, diagnostic center, and ambulatory & surgical centers. Out of which, the hospitals & clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the high number of surgical procedures performed in hospital settings, and the high number of hospitals present in the world. It was observed that more than 850,000 cardiac surgeries are performed each year in the United States. Moreover, the rising number of heart patient admissions in hospitals along with the increasing pharma sector is anticipated to augment segment growth over the forecast period.
Test (Electrocardiography, Blood Tests, Computerized Cardiac Tomography, Echocardiography, Coronary Angiography)
Furthermore, the global heart attack diagnostics market is segmented and analyzed for demand and supply by test into electrocardiography, blood tests, computerized cardiac tomography, echocardiography, coronary angiography, and others. Out of which, the electrocardiography (ECG) segment is projected to witness noteworthy growth over the forecast period. The growth of the segment is boosted by the fact that it is the first and mandatory test that is performed to diagnose heart attack when the patients get admitted to the hospitals. Based on the data provided by the World Health Organization (WHO), it was stated that in 2019, around 17.9 million people across the globe lost their lives owing to cardiovascular diseases (CVDs), out of which, 85% were caused by a heart attack. Hence, such a higher prevalence of heart attacks is estimated to hike the number of echocardiography test performed in the hospitals over the forecast period. Furthermore, there has been advancement in the ECG devices for diagnosing heart attack, and it is expected to drive the growth of the segment in the heart attack diagnostics market.
Our in-depth analysis of the global heart attack diagnostics market includes the following segments:
|
By Type |
|
|
By Test |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Heart Attack Diagnostics Industry - Regional Synopsis
The North America heart attack diagnostics market is projected to hold the largest market share by the end of 2037. The growth of market can be ascribed to the rising incidence of cardiac diseases along with huge spending on healthcare infrastructure by the regional government and other organization that are helpful to facilitate diagnostic equipment at healthcare facilities. According to the Centers for Medicare & Medicaid Services, United States healthcare expenditures reached USD 4.1 trillion in 2020, representing 19.7% of GDP. Furthermore, healthcare spending in the United States is expected to reach USD 6.2 trillion by 2028, an annual growth rate of 5.4%. Moreover, along with the technologically advanced healthcare infrastructure, the surging awareness among people for the right amount of dose of hypertension drugs, followed by the high number of people suffering from hypertension and the presence of major market players in the region are expected to drive the global heart attack diagnostics market in North America during the forecast period. Moreover, people are suffering from these diseases and disorders at a higher rate in the region since Americans consume more calories than they burn. For instance, nearly 60% of the Americans suffer from obesity in the United States which is one of the significant reasons to escalate the number of heart attack. It is estimated that every year, more than 800,000 people encounter heart attack in the USA. All these factors are, therefore, anticipated to expand the heart attack diagnostics market size in the region throughout the forecast period.
Companies Dominating the Heart Attack Diagnostics Market
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ACS Diagnostics, Company
- Asahi Kasei Corporation
- AstraZeneca PLC
- Beckman Coulter, Inc.
- Hill-Rom Services, Inc
- Koninklijke Philips N.V.
- General Electric Company
- Toshiba Corporation
- Schiller Americas, inc.
Recent Developments
-
General Electric Company, a global leader in medical technology, diagnostics and digital solutions, has launched the first AI-enabled Cath lab made in India - Optima IGS 320, enabling cardiac care in India. The lab is located at the new factory of Wipro GE Healthcare in Bengaluru. The managing director of the company further suggested that AI has the requisite potential to enhance the care pathway.
-
Abbott Laboratories to received CE marking for its first troponin test that may be able to allow prediction of heart attacks months in advance in apparently healthy adults. It can help the physicians to determine necessary medical steps to prevent heart diseases.
- Report ID: 4446
- Published Date: Apr 18, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Heart Attack Diagnostics Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
